Medical Device Developments’ Post

🧠 Viz.ai, NICO Corporation collaborate on improving intracerebral hemorrhage outcomes The collaboration will use Viz.ai’s technology that enables hospitals to detect the disease earlier and get accurate measurements of brain bleeds which are essential for determining the severity of cases. It will also leverage NICO Corporation’s technology that provides early and safe access to the brain with its BrainPath solution and maximal evacuation of the clot with the Myriad solution. The combination of technologies from both companies will facilitate broader efficiencies and enhance patient care. Viz.ai CEO and co-founder Dr Chris Mansi said: “The results of the ENRICH trial have finally shown positive treatment data on one of the most costly and deadly diseases. “We’re excited to collaborate with NICO, leveraging our broadly deployed AI platform to assist neurosurgeons in their decision-making and improve patient outcomes post intracerebral haemorrhage.” Intracerebral haemorrhage (ICH), caused by bleeding within the brain tissue, is a life-threatening type of stroke, accounts for up to 15% of all strokes, and has high morbidity and mortality rates. Read more online: https://lnkd.in/eUmcyxKq 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #vizai #nicocorporation #strokecare

  • Viz.ai, NICO Corporation collaborate on improving intracerebral hemorrhage outcomes



The collaboration will use Viz.ai’s technology that enables hospitals to detect the disease earlier and get accurate measurements of brain bleeds which are essential for determining the severity of cases.



It will also leverage NICO Corporation’s technology that provides early and safe access to the brain with its BrainPath solution and maximal evacuation of the clot with the Myriad solution.



The combination of technologies from both companies will facilitate broader efficiencies and enhance patient care.



Viz.ai CEO and co-founder Dr Chris Mansi said: “The results of the ENRICH trial have finally shown positive treatment data on one of the most costly and deadly diseases.



“We’re excited to collaborate with NICO, leveraging our broadly deployed AI platform to assist neurosurgeons in their decision-making and improve patient outcomes post intracerebral haemorrhage.”



Intracerebral haemorrh

To view or add a comment, sign in

Explore topics